首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1508741

苯二氮平類藥物市場：依產品、給藥途徑、應用、通路與地區

Benzodiazepine Drugs Market, By Product (Long Acting Benzodiazepines and Short Acting Benzodiazepines), By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月30日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年苯二氮平類藥物的全球市場規模為32.274億美元，預計2031年將達到41.995億美元，2024年至2031年複合年成長率為3.8%。

圖 1. 苯二氮平類藥物市場佔有率(%)，依地區分類，2024 年

由於主要國家焦慮和睡眠障礙盛行率上升，苯二氮平類藥物的全球市場正在顯著成長。苯二氮平類藥物是一類促效劑，用於治療失眠、焦慮、煩躁、癲癇發作、恐慌發作和肌肉痙攣等疾病，因為它們對中樞神經系統有影響。這些藥物可作為中樞神經系統抑制劑，抑制大腦異常興奮，同時誘導鎮靜。苯二氮平類藥物可增強 GABAA 受體的作用，進而調節睡眠、焦慮和肌肉張力。此外，苯二氮平類藥物廣泛用於短期治療焦慮和睡眠障礙，以及緩解酒精戒斷症狀。

市場動態：

生活方式的改變和壓力水平的增加正在增加整體焦慮症和失眠等疾病的盛行率，全球對苯二氮平類藥物的需求預計將增加。根據世界衛生組織發布的報告，全球約有2.64億人患有憂鬱症和焦慮症。根據美國焦慮和憂鬱症協會的數據，超過 38% 的美國人有焦慮症狀。擴大採用苯二氮平類藥物來治療心理健康問題的症狀，這可能會推動全球苯二氮平類藥物市場的成長。然而，諸如對長期使用苯二氮平類藥物相關副作用（如嗜睡、頭暈、協調性和記憶力下降）的擔憂等因素可能會給市場相關人員帶來挑戰。此外，替代療法的可用性也可能阻礙預測期內的市場成長。另一方面，藥物開發的進步引入了更安全、副作用更少的苯二氮平類藥物，為不久的將來市場成長提供了重大機會。

本研究的主要特點

該報告對全球苯二氮平類藥物市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（百萬美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，對全球苯二氮平類市場的主要企業進行概況分析。
所列的主要公司包括Torrent Pharmaceuticals Ltd.、Mallinckrodt Pharmaceuticals、Pfizer Inc.、Viatris (Mylan NV)、Labiana Pharmaceuticals、Bausch Health Companies, Inc.、Teva Pharmaceutical Industries Ltd.、Amneal Pharmaceuticals LLC、Sunnya Pharmaceticalseva Pharmaceutical Industriesu.、Amneal Pharmaceuticals LLC、Sunnya Pharmaceticalseva Pharmaceutical Ltd.。 UK Ltd. 、Lupin 和 Hikma Pharmaceuticals PLC。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
苯二氮平類藥物的全球市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於全球苯二氮平類市場分析的各種策略矩陣來促進他們的決策。

公司簡介
- Torrent Pharmaceuticals Ltd.
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris（Mylan NV）
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- F.Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC

第11章分析師建議

升起和降落
綜合機會圖

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5001

Global benzodiazepine drugs market is estimated to be valued at USD 3,227.4 Mn in 2024 and is expected to reach USD 4,199.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031.

Figure 1. Benzodiazepine Drugs Market Share (%), By Region, 2024

Global benzodiazepine drugs market has been witnessing significant growth due to rising prevalence of anxiety and sleep disorders across major countries. Benzodiazepines are a class of psychoactive drugs that are prescribed to treat conditions such as insomnia, anxiety, agitation, seizures, panic attacks and muscle spasms by their effect on the central nervous system. These act as central nervous system depressants, reducing abnormal excitement in the brain, while inducing sedation. Benzodiazepines enhance the effect of the GABAA receptors, which are responsible to regulating aspects of sleep, anxiety and muscle tension. Moreover, benzodiazepines are widely prescribed for short term management of anxiety and sleep disorders along with symptomatic relief of alcohol withdrawal.

Market Dynamics:

Growing prevalence of conditions like generalized anxiety disorder and insomnia due to changing lifestyle and increasing stress levels is expected to boost demand for benzodiazepine drugs globally. According to the report published by WHO, around 264 million people suffer from depression and anxiety worldwide. More than 38% of Americans had experience symptoms of anxiety, according to the Anxiety and Depression Association of America. Increasing adoption of benzodiazepines to manage symptoms of mental health issues can drive the global benzodiazepine drugs market growth. However, factors such as concerns regarding side effects associated with long term use of benzodiazepines including drowsiness, dizziness, and impaired coordination and memory can pose a challenge for market players. Moreover, availability of alternative treatments can hamper the market growth over the forecast period. Meanwhile, advancements in drug development to introduce safer variants of benzodiazepines with fewer side effects present significant opportunities for the market growth in the near future.

Key Features of the Study:

This report provides an in-depth analysis of the global benzodiazepine drugs market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global benzodiazepine drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Torrent Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Pfizer Inc., Viatris (Mylan N.V.), Labiana Pharmaceuticals, Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Par Pharmaceutical, Intas Pharmaceuticals Ltd., Neurelis, Inc., Almatica Pharma LLC, Aquestive Therapeutics, Inc., F.Hoffmann-La Roche Ltd., Wockhardt UK Ltd, Lupin, Hikma Pharmaceuticals PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global benzodiazepine drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global benzodiazepine drugs market

Detailed Segmentation

By Product:
- Long Acting Benzodiazepines
- Chlordiazepoxide
- Diazepam
- Lorazepam
- Alprazolam
- Clonazepam
- Others
- Short Acting Benzodiazepines
- Temazepam
- Midazolam
- Triazolam
- Others
By Route of Administration:
- Oral
- Injectables
- Others
By Application:
- Anxiety Disorders
- Nervousness
- Sedation
- Seizures
- Alcohol Withdrawal
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Torrent Pharmaceuticals Ltd.
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris (Mylan N.V.)
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Benzodiazepine Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Benzodiazepine Drugs Market, By Product, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Long Acting Benzodiazepines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Temazepam
Midazolam
Triazolam
Others

6. Global Benzodiazepine Drugs Market, By Route of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Benzodiazepine Drugs Market, By Application, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Anxiety Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Nervousness
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Sedation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Seizures
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Alcohol Withdrawal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Benzodiazepine Drugs Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Benzodiazepine Drugs Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Torrent Pharmaceuticals Ltd.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris (Mylan N.V.)
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- F.Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC